A gold mine for drug discovery: Strategies to develop cyclic peptides into therapies
The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
As a versatile therapeutic modality, peptides attract much attention because of their great binding affinity, low toxicity, and the capability of targeting traditionally “undruggable” protein surfaces. However, the deficiency of cell permeability and metabolic stability always limits the success of in vitro bioactive peptides as drug candidates. Peptide macrocyclization is one of the most established strategies to overcome these limitations. Over the past decades, more than 40 cyclic peptide drugs have been clinically approved, the vast majority of which are derived from natural products. The de novo discovered cyclic peptides on the basis of rational design and in vitro evolution, have also enabled the binding with targets for which nature provides no solutions. The current review summarizes different classes of cyclic peptides with diverse biological activities, and presents an overview of various approaches to develop cyclic peptide‐based drug candidates, drawing upon series of examples to illustrate each strategy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Activation of Apoptosis in Vivo by a Hydrocarbon-Stapled BH3 Helix
Walensky, L. D., Kung, A. L., Escher, I., Malia, T. J., Barbuto, S., Wright, R. D., Wagner, G., Verdine, G. L., & Korsmeyer, S. J. (2004) · Science · doi:10.1126/science.1099191 · Cited by 1,349
Contemporary strategies for peptide macrocyclization
White, C. J., & Yudin, A. K. (2011) · Nature Chemistry · doi:10.1038/nchem.1062 · Cited by 1,088
Schafmeister, C. E., Po, J., & Verdine, G. L. (2000) · Journal of the American Chemical Society · doi:10.1021/ja000563a · Cited by 1,037
Wall Teichoic Acids of Gram-Positive Bacteria
Brown, S., Santa Maria, J. P., & Walker, S. (2013) · Annual Review of Microbiology · doi:10.1146/annurev-micro-092412-155620 · Cited by 966
Mechanism of oligonucleotide release from cationic liposomes.
Zelphati, O., & Szoka, F. C. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.21.11493 · Cited by 634
Ton-That, H., Liu, G., Mazmanian, S. K., Faull, K. F., & Schneewind, O. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.22.12424 · Cited by 567 · cited 1×
“aureus, is one of the most commonly used bioengineering tools for peptide cyclization.(195) Through Srt‐mediated ligation (SML), antibacterial cyclopeptide P‐113 and its analogs (Figure 29B) have been synthesized successfully with high yields.”
BackgroundImproving Oral Bioavailability of Peptides by Multiple N‐Methylation: Somatostatin Analogues
Biron, E., Chatterjee, J., Ovadia, O., Langenegger, D., Brueggen, J., Hoyer, D., Schmid, H. A., Jelinek, R., Gilon, C., Hoffman, A., et al. (2008) · Angewandte Chemie International Edition · doi:10.1002/anie.200705797 · Cited by 374 · cited 1×
“Another example of this strategy was a tri‐N‐methylated somatostatin analog (Figure 33B), which exhibited high oral bioavailability.(229) In 2011, White et al(230) developed an on‐resin N‐ methylation method and prepared several cyclic peptides with drug‐like oral bioavailability and membrane permeability.”
Pogliano, J., Pogliano, N., & Silverman, J. A. (2012) · Journal of Bacteriology · doi:10.1128/jb.00011-12 · Cited by 319 · cited 1×
“Then, an aggregation of daptomycin occurs in the same position, which leads to the rupture of the membrane and bacterial cell death.(58)”
BackgroundGeneral approach to the synthesis of short .alpha.-helical peptides
Jackson, D. Y., King, D. S., Chmielewski, J., Singh, S., & Schultz, P. G. (1991) · Journal of the American Chemical Society · doi:10.1021/ja00024a067 · Cited by 313
Harrison, R. S., Shepherd, N. E., Hoang, H. N., Ruiz-Gómez, G., Hill, T. A., Driver, R. W., Desai, V. S., Young, P. R., Abbenante, G., & Fairlie, D. P. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1002498107 · Cited by 182 · cited 1×
“For example, a doubly lactam‐stapled peptide displayed powerful inhibitory activity against respiratory syncytial virus; a quorum sensing peptide CSP‐1 stapled by lactamisation exhibited enhanced antibacterial activity (Figure 47A); and a lactam‐stapled peptide derived from mRNA transport protein HIV Rev showed improv…”
MethodChemical Synthesis of Circular Proteins
Tam, J. P., & Wong, C. T. T. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.r111.323568 · Cited by 172
Cited by
Li, Y., Li, W., & Xu, Z. (2021) · Marine Drugs · doi:10.3390/md19060311 · Cited by 59
Metadata
- Authors
- Jing, X., & Jin, K.
- Venue
- Medicinal Research Reviews
- Publisher
- Wiley
- Published
- 2019-10-09
- Volume
- 40
- Issue
- 2
- Pages
- 753-810
- ISSN
- 0198-6325 (ISSN-L)
- 1098-1128
- OpenAlex
- W2979997670
- Cited by
- 164
- References
- 11
- FWCI
- 5.87
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.